Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Express Scripts
Baxter
Harvard Business School
Boehringer Ingelheim

Last Updated: June 26, 2022

Litigation for ECULIZUMAB


✉ Email this page to a colleague

« Back to Dashboard

US Court Litigation for ECULIZUMAB

Glossary
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
8,420,081 See Plans and Pricing See Plans and Pricing 2021-05-11 2021-05-12 28:2201 Declaratory Judgment District Court, E.D. Virginia Plaintiff See Plans and Pricing
8,420,081 See Plans and Pricing See Plans and Pricing 2021-04-27 2022-03-08 42:1983 Prisoner Civil Rights District Court, N.D. Illinois Plaintiff See Plans and Pricing
8,420,081 See Plans and Pricing See Plans and Pricing 2021-05-28 2022-03-08 35:271 Patent Infringement District Court, N.D. Illinois Defendant See Plans and Pricing
8,420,081 See Plans and Pricing See Plans and Pricing 2021-10-22 2021-11-05 02:431 Fed. Election Commission: Failure Enforce Compliance District Court, N.D. Illinois See Plans and Pricing
8,420,081 Shipp v. Gomez See Plans and Pricing 2022-02-16 2022-03-08 42:1983 Prisoner Civil Rights District Court, N.D. Illinois Plaintiff See Plans and Pricing
8,420,081 Stegmann v. PetSmart LLC See Plans and Pricing 2022-03-03 2022-03-08 28:1332 Diversity-Petition for Removal District Court, N.D. Illinois None See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or Sign up for a Free Trial

Patent Trial and Appeal Board Cases for ECULIZUMAB

Glossary
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,420,081 See Plans and Pricing 2017-12-20 Wolfgang FRAUNHOFER et al 106 See Plans and Pricing Wolfgang FRAUNHOFER et al See Plans and Pricing
9,718,880 Amgen Inc. See Plans and Pricing 2019-02-28 02-28-2019 BELL et al Inter partes review See Plans and Pricing 08-30-2019 See Plans and Pricing
9,732,149 Amgen, Inc. See Plans and Pricing 2019-02-28 02-28-2019 BELL et al Inter partes review See Plans and Pricing 08-30-2019 See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or Sign up for a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Baxter
Moodys
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group